Don’t worry, be Appy! Businesswoman creates App to help cancer sufferers get better care
An app for patients diagnosed with cancer, which will guide them through different stages of therapy, help coordinate treatment and rehabilitation, as well as provide useful tips has been designed by a Polish start-up.
The Mednavi is a ‘first aid kit’ for those, who find themselves lost after being diagnosed with cancer.
Ina Dźwierzyńska, the founder and initiator behind the start-up, came up with the idea after her own experience with the disease.
At first she was told her tumour was incurable and only after extensive research did she find a doctor in a different city who was able to treat her.
What seemed impossible in Warsaw, became possible in Bydgoszcz.
She said: “Shouldn’t all patients deserve the best possible treatment? What can be done so that all patients can quickly find out where to go and what options are available?
“This is what I was thinking a few days after my brain surgery. This is how Mednavi’s idea was born.”
The app combines the knowledge of where to go for treatment with what kind of treatment is required for different types of cancer.
The patient can check the treatment patterns of individual cancers, view profiles of almost 600 hospitals and other facilities and read expert advice.
The idea is promoted through the initiative #swiatdogorynogami (#worldturnedonitshead) with the pro bono support of Polish celebrities such as Krystyna Janda, Olivier Janiak and Natalia Siwiec.
For Ina, who had a real estate company before, Mednavi is not just a new business, but a cause she believes in due to her personal experience.
The application can be installed on your computer, tablet and smartphone.
Currently, there are full sets of information for breast, colon, prostate, stomach, pancreas, ovary and brain cancer patients.
However the app is still being developed - in a few days it will also include liver cancer patients, while versions to help treat melanoma and lung, kidney, stem and cervical cancer are still being developed.